Suppr超能文献

遗传性骨病患者子女存在失明风险。

Potential blindness in children of patients with hereditary bone disease.

作者信息

Kheir V, Munier F L, Aubry-Rozier B, Schorderet D F

机构信息

IRO - Institute for Research in Ophthalmology, Av. du Grand-Champsec 64, 1950, Sion, Switzerland.

Department of Ophthalmology, Jules-Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland.

出版信息

Osteoporos Int. 2016 Feb;27(2):841-4. doi: 10.1007/s00198-015-3245-4. Epub 2015 Aug 5.

Abstract

Mono- and bi-allelic mutations in the low-density lipoprotein receptor related protein 5 (LRP5) may cause osteopetrosis, autosomal dominant and recessive exudative vitreoretinopathy, juvenile osteoporosis, or persistent hyperplastic primary vitreous (PHPV). We report on a child affected with PHPV and carrying compound mutations. The father carried the splice mutation and suffered from severe bone fragility since childhood. The mother carried the missense mutation without any clinical manifestations. The genetic diagnosis of their child allowed for appropriate treatment in the father and for the detection of osteopenia in the mother. Mono- and bi-allelic mutations in LRP5 may cause osteopetrosis, autosomal dominant and recessive exudative vitreoretinopathy, juvenile osteoporosis, or PHPV. PHPV is a component of persistent fetal vasculature of the eye, characterized by highly variable expressivity and resulting in a wide spectrum of anterior and/or posterior congenital developmental defects, which may lead to blindness. We evaluated a family diagnosed with PHPV in their only child. The child presented photophobia during the first 3 weeks of life, followed by leukocoria at 2 months of age. Molecular resequencing of NDP, FZD4, and LRP5 was performed in the child and segregation of the observed mutations in the parents. At presentation, fundus examination of the child showed a retrolental mass in the right eye. Ultrasonography revealed retinal detachment in both eyes. Thorough familial analysis revealed that the father suffered from many fractures since childhood without specific fragility bone diagnosis, treatment, or management. The mother was asymptomatic. Molecular analysis in the proband identified two mutations: a c.[2091+2T>C] splice mutation and c.[1682C>T] missense mutation. We report the case of a child affected with PHPV and carrying compound heterozygous LRP5 mutations. This genetic diagnosis allowed the clinical diagnosis of the bone problem to be made in the father, resulting in better management of the family. It also enabled preventive treatment to be prescribed for the mother and accurate genetic counseling to be provided.

摘要

低密度脂蛋白受体相关蛋白5(LRP5)的单等位基因和双等位基因突变可能导致骨硬化症、常染色体显性和隐性渗出性玻璃体视网膜病变、青少年骨质疏松症或永存原始玻璃体增生症(PHPV)。我们报告了一名患有PHPV且携带复合突变的儿童。父亲携带剪接突变,自幼患有严重的骨质脆弱。母亲携带错义突变,但无任何临床表现。对他们孩子的基因诊断使得父亲能够得到适当治疗,并检测出母亲患有骨质减少症。LRP5的单等位基因和双等位基因突变可能导致骨硬化症、常染色体显性和隐性渗出性玻璃体视网膜病变、青少年骨质疏松症或PHPV。PHPV是眼部永存胎儿血管的一个组成部分,其特征为表达高度可变,会导致广泛的前部和/或后部先天性发育缺陷,可能导致失明。我们评估了一个仅在其独子身上被诊断为PHPV的家庭。该儿童在出生后的前3周出现畏光症状,2个月大时出现白瞳症。对该儿童进行了NDP、FZD4和LRP5的分子重测序,并在父母中对观察到的突变进行了分离分析。就诊时,该儿童的眼底检查显示右眼有晶状体后肿块。超声检查显示双眼视网膜脱离。全面的家族分析显示,父亲自幼患有多处骨折,但未进行过具体的脆性骨诊断、治疗或管理。母亲无症状。对先证者的分子分析鉴定出两个突变:一个c.[2091+2T>C]剪接突变和一个c.[1682C>T]错义突变。我们报告了一名患有PHPV且携带复合杂合LRP5突变的儿童病例。这一基因诊断使得能够对父亲的骨骼问题进行临床诊断,从而更好地管理这个家庭。它还使得能够为母亲开出预防性治疗药物,并提供准确的遗传咨询。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验